What should standard frontline therapy be in older patients with chronic lymphocytic leukemia? Ibrutinib should be standard frontline therapy.

What should standard frontline therapy be in older patients with chronic lymphocytic leukemia? Ibrutinib should be standard frontline therapy. Clin Adv Hematol Oncol. 2016 May;14(5):330-3 Authors: Woyach JA PMID: 27379693 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/27379693?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - July 7, 2016 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research

More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia